A detailed history of Gries Financial LLC transactions in Incyte Corp stock. As of the latest transaction made, Gries Financial LLC holds 4,525 shares of INCY stock, worth $465,713. This represents 0.07% of its overall portfolio holdings.

Number of Shares
4,525
Previous 4,620 2.06%
Holding current value
$465,713
Previous $314,000 21.97%
% of portfolio
0.07%
Previous 0.07%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 22, 2025

SELL
$67.27 - $86.96 $6,390 - $8,261
-95 Reduced 2.06%
4,525 $383,000
Q2 2025

Jul 14, 2025

BUY
$55.17 - $71.22 $254,885 - $329,036
4,620 New
4,620 $314,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $22.9B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Gries Financial LLC Portfolio

Follow Gries Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gries Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gries Financial LLC with notifications on news.